-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk's adjusted Wegovy oral drug sales for the third quarter were DKK 5.39 billion, and the market expected DKK 4.64 billion.

Zhitongcaijing·11/04/2026 06:41:12
Listen to the news
Novo Nordisk's adjusted Wegovy oral drug sales for the third quarter were DKK 5.39 billion, and the market expected DKK 4.64 billion.